Koyfin Home > Directory > Health Care > Amedisys Inc > Long-Term Debt

Amedisys Inc Long-Term Debt Chart (AMED)

Amedisys Inc annual/quarterly Long-Term Debt from 2010 to 2020.
  • Amedisys Inc Long-Term Debt for the quarter ending June 06, 2020 was $390m a 41.09% increase of 160m year over year
  • Amedisys Inc Long-Term Debt for the last 12 months ending June 06, 2020 was $390m a 41.09% increase of 160m year over year
  • Amedisys Inc Annual Long-Term Debt for 2019 was $231m a 97.50% increase of 225m from 2018
  • Amedisys Inc Annual Long-Term Debt for 2018 was $6m a -1,254.16% decrease of -72m from 2017
  • Amedisys Inc Annual Long-Term Debt for 2017 was $78m a -12.28% decrease of -10m from 2016
Other Cash Flow Metrics:
  • Amedisys Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $64m a 37.04% increase of 24m year over year
  • Amedisys Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $47m a 41.63% increase of 20m year over year
  • Amedisys Inc Total Revenue for the quarter ending December 12, 2018 was $434m a 8.08% increase of 35m year over year
View Chart On Koyfin

Quarterly AMED Long-Term Debt Data

06/2020$390m
03/2020$377m
12/2019$231m
09/2019$230m
06/2019$265m
03/2019$302m
12/2018$6m
09/2018$55m
06/2018$124m
03/2018$76m

Annual AMED Long-Term Debt Data

2019$231m
2018$6m
2017$78m
2016$88m
2015$92m
2014$104m
2013$33m
2012$67m
2011$112m
2010$145m